PA

Pallavi Amol Ravankar

Active Director Designated Partner DIN 10584938
DIN 10584938 First appointment Apr 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Pallavi Amol Ravankar

Data last updated:

Pallavi Amol Ravankar is a Designated Partner at Biosculpt Pharma Llp (since 2024).

DIN 10584938
Primary Designation Designated Partner
First Appointment 09 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Apr 20242024Active

Board colleagues of Pallavi Amol Ravankar

NameDINCompanyDesignation
Premanand Motiramji Lahane10584937Biosculpt Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Biosculpt Pharma Llp
Premium access

Shareholding and investment profile for Pallavi Amol Ravankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pallavi Amol Ravankar

Pallavi Amol Ravankar currently holds 1 directorship: Biosculpt Pharma Llp (Designated Partner, since 09 Apr 2024).

Pallavi Amol Ravankar was first appointed on 09 Apr 2024 as Designated Partner at Biosculpt Pharma Llp.

The current boards of Pallavi Amol Ravankar's companies include Premanand Motiramji Lahane (Biosculpt Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available